f Case report. We describe an unusual case of pelvic lymph node endometriosis with an aberrant immunophenotype mimicking metastasis of adenocarcinoma. A 37-year-old patient with a history of invasive cervical adenocarcinoma stage pT1a2 is presented. Due to insufficient loop electrosurgical excision procedure (LEEP) conization, total laparoscopic hysterectomy with pelvic lymphadenectomy was indicated. Intraoperatively, the diagnosis of deep infiltrating endometriosis of parametrial ligament and vesicouterine pouch, endometrioma of the left ovary and Allen Master's syndrome was suspected; the patient had no history or clinical symptoms of endometriosis. A PubMed search of similar cases was followed by a comparison to this case and discussion of the differential diagnosis of glandular lesions in the pelvic lymph nodes is reported. Results. Histological investigation showed no residual neoplasia; the diagnosis of endometriosis was confirmed. An interesting microscopic finding was represented by a solitary glandular lesion in one pelvic lymph node. Using immunohistochemistry, it was demonstrated that there was a complete loss of oestrogen and progesterone receptor expression (unlike parametrial ligament endometriosis). The diagnosis of endometriosis was based on the presence of endometrial stroma; malignancy was excluded by bland cytomorphologic features and results of immunohistochemical examination.
INTRODUCTION
Endometriosis represents a common, chronic, estrogen-dependent gynaecologic disorder and is defined as the presence of endometriotic glandular and stromal tissue outside the uterine corpus [1] [2] [3] . It is found in approximately 5-10% of premenopausal women 3, 4 . The typical symptoms of endometriosis include chronic pelvic pain of varying intensity (50-90% of women), infertility (20-50% of women), dysmenorrhea (50% of women) and dyspareunia (25-50% of women), thus endometriosis represents one of the major causes of morbidity in premenopausal women. Endometriosis of the urinary bladder may result in dysuria or hematuria. The main symptoms of bowel endometriosis are dyschezia and rectorrhagia 5, 6 . The most commonly affected organs are the peritoneum, ovaries, fallopian tubes, uterus, vagina, urinary bladder and rectosigmoideum. In contrast, it is uncommon to find endometriosis in sites such as the cicatrice, umbilicus, omentum, lymph nodes, lungs, heart or bones 7, 8 . The definite cause of endometriosis remains unclear. Many theories have been proposed to explain the pathogenesis of endometriosis and to date they all remain inconclusive (implantation, regurgitation, metaplastic, iatrogenic, immunologic, molecular-genetic theory, theory of tissue injury, vascular and lymphatic dissemination, and stem cell theory) (ref. [9] [10] [11] [12] [13] ). While considered a benign disorder, endometriosis shares a number of similarities with malignant diseases, such as an abnormal morphology, deregulated cell growth, cellular invasion, neoangiogenesis, DNA aneuploidy, loss of heterozygosity, recurrence, migration along the nerve bundles, metastatic spread to lymph nodes and distant organs 14 .
Malignant transformation of endometriosis is rare and affects 1% of lesions with the ovary being the primary site in 79% (ref. [15] [16] ). Lymphatic spread of endometriosis to lymph nodes has been documented as a frequent event (25-42%) in bowel, rectosigmoid and rectovaginal endometriosis [17] [18] [19] . Lymph node involvement by endometriosis consists of isolated endometriotic-like cells (IELC) located in the subcapsular sinus of lymph nodes, representing an early stage of involvement, and frank metastatic endometriotic lesions 18 . An unusual case of pelvic lymph node endometriosis with an aberrant immunophenotype mimicking metastasis of adenocarcinoma is described as follows:
CASE REPORT
A 37-year-old woman, smoker, G2P2, with no history or symptoms of endometriosis was referred to our department for invasive cervical adenocarcinoma stage FIGO IA2. Histological examination showed endocervical adenocarcinoma of the usual type, well differentiated, with stromal invasion of 3.5 mm, horizontal spread of 4 mm and presence of strong nuclear and cytoplasmic expression of p16; the information about vascular invasion was not included in the pathology report. Cervical cytology specimens were repeatedly classified as atypical squamous cells of undetermined significance (ASCUS). The diagnosis as well as the initial LEEP conization of the cervix with a positive margin were performed at another hospital. The ultrasonographic examination showed normal pelvic area (without free fluid or adhesions). The only positive finding was 36x32 mm left ovarian cystic lesion, the so called endometrioma. Consequently, the patient underwent a total laparoscopic hysterectomy with pelvic lymphadenectomy at this hospital. Intraoperatively, the diagnosis of deep infiltrating endometriosis of parametrial ligament and vesicouterine pouch, endometrioma of the left ovary and Allen Master´s syndrome was suspected (Fig. 1) . The histological examination then confirmed the diagnosis.
For classification of endometriosis the revised American Society for Reproductive Medicine (rASRM) score (stage IV) and ENZIAN classification (B1) were used.
Histopathology
At the department of pathology 6 separate materials were evaluated: left fallopian tube (1), right fallopian tube (2), left ovary (3), uterus including parametrial ligaments (4), right pelvic lymph nodes (5), left pelvic lymph nodes (6) . The Materials were extensively investigated using 102 tissue sections stained with hematoxylin-eosin. The uterine cervix was completely processed; no residual epithelial dysplasia or invasive neoplasia was found. Endometriosis of the left ovary, uterine cervix, parametrial ligaments and vesicouterine pouch represented an incidental histological finding.
Particularly interesting in relation to the clinical context of cervical adenocarcinoma, was the finding of a solitary gland with cystic dilatation in one of the total of 36 regional pelvic lymph nodes. To determine the nature of the lesion a wide range of immunohistochemical antibodies was used. The gland stained positively with cytokeratin AE1/AE3 (AE1/AE3), cytokeratin 7 (CK7) and negatively with cytokeratin 20 (CK20), p16 (unlike cervical adenocarcinoma), p53, carcinoembryonic antigen (CEA), vimentin, oestrogen and progesterone receptors (ER, PR). Staining with the antibody against CD10 revealed a narrow rim of subjacent stromal cells which coexpressed vimentin, ER and PR ( Fig. 2a-c) .
For comparative reasons, we found immunoprofile of parametrial ligament endometriosis with the following results -both stromal and glandular immunonegativity for p16, p53, CEA and CK20, only stromal immunopositivity for CD10, only glandular immunopositivity for AE1/ AE3 and CK7, stromal and glandular immunopositivity for vimentin, ER and PR (Fig. 2d,e) .
A final diagnosis of lymph node endometriosis with an aberrant immunophenotype was made.
DISCUSSION
This case report represents a challenging differential diagnosis of glandular lesions in the pelvic lymph nodes.
It was necessary to differentiate between metastasis of cervical and colorectal adenocarcinoma, lymph node endometriosis and benign glandular inclusions of müllerian type. Histologically we found a solitary gland with cystic dilatation lined by a single layer or pseudostratified columnar epithelium with mild nuclear atypia (reactive) and low mitotic rate (without atypical mitotic figures) (Fig.  2f) . The diagnosis of malignancy was excluded through a lack of significant cellular atypia and mitotic activity, interfollicular location of the gland and an absence of a desmoplastic stromal reaction.
Müllerian glandular inclusions are found in approximately 5% of pelvic lymph node dissections performed for staging of malignant neoplasms such as ovarian or cervical carcinoma, or other gynaecological surgeries. These are almost always incidental microscopic findings [20] [21] [22] . They are most commonly lined by a single layer of cuboidal to columnar tubal-type epithelium (endosalpingiosis), but sometimes by benign endometrioid epithelium 23 , mucinous epithelium of endocervical [24] [25] or goblet-cell type 26 , or metaplastic squamous epithelium 27 ; an admixture of different types of müllerian glands within a lymph node is designated as müllerianosis. Endosalpingiosis is sometimes associated with endometriosis 26 . Therefore the distinction between endometriosis and müllerian glandular inclusions was based on the presence of endometrial stroma.
Using immunohistochemistry, a complete loss of oestrogen and progesterone receptor expression in the endometriotic gland in the pelvic lymph node was identified. From a pathological point of view, this type of aberrant immunophenotype is very unusual. This phenomenon is not fully understood but possible causes could be metaplastic processes or transformation in atypical endometriosis.
The result of immunohistochemistry may be affected by different methodological approaches. Mouse monoclonal antibodies, which generally show a higher specificity when compared with polyclonal antibodies, were used in this case. Maximum effort was applied to prevent the well known technical and interpretative pitfalls of this methodological approach. All immunohistochemical analyses, including antigen retrieval, were performed in the same laboratory specialized for immunohistochemistry while adhering to standardized protocols. To avoid nonspecific background staining, the system of positive and negative controls was used. For confirmation of this unusual finding, immunohistochemistry was repeatedly performed.
Similar to this study, in 1994 Brandau and co-workers described a case report of an endometriosis in retroperitoneally situated lymph nodes in a 29-year-old patient. The patient had a cervical carcinoma stage FIGO Ib and was treated surgically by radical hysterectomy after Wertheim-Meigs-Okabayashi with pelvic lymphadenectomy. Coincidentally endometriosis was found in two lymph nodes of the retroperitoneum. The patient had no history or clinical symptoms of endometriosis. Endometriosis could not be found in any other parts of the abdomen. Additionally, an aberrant immunophenotype of the endometriotic gland in a lymph node with only progesterone receptor expression and loss of oestrogen receptor expression was found 28 . Glandular lesions in the lymph nodes was first described by Ries in 1897 in patients who underwent a hysterectomy and pelvic lymphadenectomy for cervical cancer 29 .
Recently, it has been observed that regional lymph node involvement by endometriosis is a common phenomenon in women with coincidentally found bowel endometriosis 30 . Endometriotic spread to the lymphatic system is poorly understood and little is known about the molecular events and changes in gene expressions associated with this process. In 2011, Tempfer and colleagues analyzed regional lymph node-spread into pelvic sentinel lymph node (PSLN) in a prospective study of 23 patients with ovarian and/or peritoneal endometriosis. They found endometriotic lesions in 11% and the presence of IELC in 80% of PSLN (ref. 31 ). The study by Bürkle and associates, published in 2013, indicates that the spread of endometriosis to PSLN is accompanied by different expressions of several genes, including EPCAM, CDH1 (E-cadherin), CXCR4 and CD44. Using quantitative real-time PCR and immunohistochemistry they analyzed the expression levels of a panel of 28 genes previously described to be associated with endometriosis in a series of samples of primary endometriotic lesions, IELC-negative PSLN and IELC-positive PSLN. Expression of a set of genes (CXCR4, CD68, MKI67 and CD44) was found to be higher in IELC-positive PSLN than in IELC-negative PSLN, while lowest in endometriotic lesions, indicating up-regulation in IELC. In contrast, EPCAM and E-cadherin, which were strongly expressed in endometriotic lesions, were not found to be expressed in IELC-positive PSLN. Study showed that prerequisites for the transition appear to be the up-regulation of the chemokine receptor CXCR4 and CD44 isoforms (including CD44v6 isoform), and the loss of expression of epithelial markers such as E-cadherin and EPCAM. The next step, establishment of an endometriotic lesion with the lymph node, appears to be accompanied by reexpression of epithelial markers such as cytokeratins, E-cadherin and EPCAM (ref. 32 ). These data are consistent with results published by Ruiz et al. who also found significantly higher CXCR4 expression in endometriotic lesions compared to normal endometrium 33 . In 2012 Ji published that macrophages act as a direct structure contributor to lymphatic endothelial walls or secrete a vascular endothelial growth factor (VEGF) to initiate lymphangiogenesis in inflamed or tumor tissues 34 . This finding, together with the fact that endometriosis is an inflammatory disorder with an increased concentration of macrophages, indicates the possible role of macrophages in the process of lymph node involvement by endometriosis.
To our knowledge, the scientific literature does not describe endometriosis with an aberrant immunophenotype with complete loss of oestrogen and progesterone receptor expression.
Immunohistochemical hormonal receptor expression in eutopic and ectopic endometrium was analyzed by Jones and co-workers in a series of 30 women with endometriosis. They found an increased oestrogen receptor expression in ectopic endometrium from the proliferative to the late secretory phase. Compared with the eutopic endometrium, the expression in both epithelium and stroma of ectopic endometrium was significantly higher throughout the cycle. In contrast, stromal progesterone receptor expression tended to be reduced in ectopic endometrium compared with eutopic tissue, while epithelial progesterone receptor expression was increased in ectopic endometrium only in the late secretory phase 35 . Despite the variable intensity of hormonal receptor expression, all cases showed typical immunophenotype with immunopositivity for both oestrogen and progesterone receptors. In searching the literature, no publication describing heterogeneous expression of estrogen and progesterone receptors in eutopic and ectopic endometrium was found.
Mechsner et al. retrospectively analyzed the frequency of endometriotic lesions and disseminated endometrioticlike cells in a series of 108 coincidentally resected lymph nodes of 24 patients with endometriosis. Endometriotic lesions were detected in 8 out of 24 patients, while disseminated endometriotic-like cells were found in 17 out of the 24 patients. The study showed typical immunophenotype in all cases (endometriotic lesions stained positively with ER, PR, CD10 and cytokeratin, endometriotic-like cells stained positively with ER and PR) (ref. 36 ). Currently, little is known about the mechanism of recurrence of endometriosis and its management is not efficacious. After surgical and/or medical therapy, endometriosis has a high recurrence rate which increases with the length of follow-up. To delay or eliminate recurrence is the main goal in the control of this disease 30 . Only a limited number of studies investigated the clinical significance of lymph node involvement by endometriosis with somewhat conflicting results. The most recent study by Rossini and colleagues from 2016 analyzed correlation between the severity of endometriosis and lymph node involvement. The study included 140 cases of colorectal surgery for intestinal endometriosis; histopathological examination revealed the involvement in 50% of the cases. They showed no statistically significant correlation between the positivity of lymph nodes and the rate of intestinal stenosis or the histopathological specimen infiltration rate and depth and the intestinal recurrence rate. Based on these results, they hypothesized that lymph node involvement in intestinal resection specimens does not modify the natural history of the disease 37 . Conversely, in the study by Gong and Tempfer, endometriotic cells in regional lymph nodes were described as a potential target of hormonal stimulation in the postoperative period and they could be a major source of disease recurrence 30 .
In 2011 Namkung at al. reported that rectal endometriosis has the ability to invade adjacent tissue as true malignant tumors and therefore, lymph node involvement should be considered in rectal endometriosis 38 .
CONCLUSION
The coincidence of a cervical adenocarcinoma and endometriosis in pelvic lymph nodes may represent a differential diagnostic problem. Confirmation of the correct diagnosis requires the use of a wide range of immunohistochemical antibodies. In the case of an aberrant immunophenotype with loss of oestrogen and progesterone receptor expression of the endometriotic gland, the finding of CD10-positive endometrial stromal cells and benign morphology of the glandular lesion is essential for proper diagnosis. To our knowledge, this type of aberrant immunophenotype of the endometriotic gland has never been presented in any scientific literature. This finding plays a significant role from a pathology standpoint and perhaps, even more importantly, from the clinical standpoint. The asymptomatic patient with the correct diagnosis of lymph node endometriosis did not undergo excessive treatment for false positive diagnosis of metastatic cervical adenocarcinoma.
Currently, little is known about the mechanism of lymph node spread of endometriosis. The question remains whether lymph node endometriosis is a significant prognostic factor and will affect the therapeutic approach to this disorder in the future. Thus, the presence of lymph node involvement with endometriotic cells may perhaps point toward a systemic aspect of this disease and the resection of regional lymph nodes could decrease the recurrence rate of endometriosis. 
